$Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization$
Código QR

Código QR

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization

Ahmad M Mansour,1,2 Friederike Mackensen,3 Padmamalini Mahendradas,4 Moncef Khairallah,5 Timothy YY Lai,6 Ziad Bashshur11Department of Ophthalmology, American University of Beirut, 2Rafic Hariri University Hospital, Beirut, Lebanon; 3Interdisciplinary Uveitis Center, University of Heidelberg, Heidel...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mansour AM, Mackensen F, Mahendradas P, Khairallah M, Lai TY, Bashshur Z
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ea3ccae7544743858a37bcaf60f0399d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala NV, et al.
Publicado: (2014)

The effect of intravitreal bevacizumab (Avastin&reg;) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Ehud Rechtman, et al.
Publicado: (2011)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Jia-Kang Wang, et al.
Publicado: (2018)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Neeraj Pandey, et al.
Publicado: (2010)

Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey HM, et al.
Publicado: (2011)

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
por: Canut MI, et al.
Publicado: (2011)

Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy
por: Grimelda Yuriana S&aacute;nchez-Castro, et al.
Publicado: (2008)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ioannis D Ladas, et al.
Publicado: (2008)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Kubota-Taniai M, et al.
Publicado: (2011)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in na&iuml;ve myopic choroidal neovascularization
por: Bergamini F, et al.
Publicado: (2012)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Yoshikawa T, et al.
Publicado: (2015)

Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
por: Noor NA, et al.
Publicado: (2017)

Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion
por: Aya Kodama, et al.
Publicado: (2010)

Is monthly retreatment with intravitreal bevacizumab (Avastin&reg;) necessary in neovascular age-related macular degeneration?
por: Nicola G Ghazi, et al.
Publicado: (2010)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Mamdouh M Kabeel, et al.
Publicado: (2008)

Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration
por: P William Conrad, et al.
Publicado: (2008)

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
por: Lemos-Reis R, et al.
Publicado: (2014)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
por: Saquib Naeem, et al.
Publicado: (2019)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
por: Shakarchi FI, et al.
Publicado: (2018)

Bevacizumab (Avastin&reg;) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Dimitrios Brouzas, et al.
Publicado: (2009)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
por: Khanani AM, et al.
Publicado: (2019)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mary F Mulcahy
Publicado: (2008)

Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah NV, et al.
Publicado: (2012)

Case of endophthalmitis following intravitreal injections of bevacizumab
por: Shinya Komori, et al.
Publicado: (2010)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
por: Eltutar K, et al.
Publicado: (2013)

The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy
por: Nitta F, et al.
Publicado: (2014)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011)

Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
por: Villegas VM, et al.
Publicado: (2014)

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
por: Ashraf M El-Batarny
Publicado: (2009)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
por: Sinapis C, et al.
Publicado: (2011)

Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab
por: Allegrini D, et al.
Publicado: (2021)

Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
por: Hirose M, et al.
Publicado: (2014)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
por: Zola M, et al.
Publicado: (2017)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho G, et al.
Publicado: (2020)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon S, et al.
Publicado: (2014)

Acute sterile endophthalmitis following intravitreal bevacizumab: case series
por: Orozco-Hernández A, et al.
Publicado: (2014)

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
por: Antonopoulos C, et al.
Publicado: (2011)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa R, et al.
Publicado: (2012)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir M, et al.
Publicado: (2011)

Reduction of Intraocular Pressure Spikes Due to Intravitreal Bevacizumab Injections by Scleral Indentation with Cotton Swab or Digital Ocular Massage: Innovative Techniques Compared
por: Nuzzi R, et al.
Publicado: (2020)